Mike Griffiths
FEBRUARY 18, 2021
Two years ago, the list of largest all-remote companies were nearly all software companies. Companies such as Humana (health insurance), Amgen (biotech), Automattic (web tools) are not only all-remote, digital success stories – they also run a lot of employee-led experiments. The world of work is changing. Transforming Purpose.
Chief Executive
NOVEMBER 3, 2022
Line clearance is most commonly used in regulated industries, such as pharmaceuticals, biotech, and food and beverage manufacturing. All of this needs to be addressed before factory operations can move at software speed. Often, operators need the use of their hands and must take pictures with a wearable camera.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Harvard Business Review
MAY 16, 2011
In its heyday, when Sun sold servers running its proprietary architecture and software, the company bought semiconductors from major vendors, such as Fujitsu in Japan. The Sun-Netscape Alliance was formed when AOL acquired Netscape in 1998 but then sought to spin out the software operations of Netscape.
Harvard Business Review
MAY 27, 2014
Germany does a better job on innovation in areas as diverse as sustainable energy systems, molecular biotech, lasers, and experimental software engineering. Reading the headlines, you might think that the most urgent question about national success in innovation and growth is whether the U.S. or China should get the gold medal.
Harvard Business Review
AUGUST 24, 2015
Some argue that the low-hanging fruit has already been picked: the IT revolution has run its course and other new technologies like biotech have yet to make a major impact on our lives. Fourth, investment in innovation should extend beyond technology to include skills, software, organisational know-how (i.e. managerial quality).
Harvard Business Review
JULY 14, 2017
It’s an illustration of how, just as the internet didn’t stop at revolutionizing the computer industry, the impacts of advances in synthetic biology won’t be limited to biotech.
Harvard Business Review
NOVEMBER 28, 2016
You don’t have to be a programmer in Silicon Valley or a gene splicer in biotech to unleash exciting innovations and create huge value. I spent the last 18 months researching and writing a book on how organizations and leaders can do extraordinary things, even if they operate in pretty ordinary fields.
Expert insights. Personalized for you.
71 
Let's personalize your content